dna anne wojcicki - Search News

News

Anne Wojcicki to buy back 23andMe and its data

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

MedTech Dive · 38m

Anne Wojcicki wins bid to buy back 23andMe for $305M

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

Seeking Alpha on MSN · 2h

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a non-profit led by the company’s co-founder and former CEO Anne Wojcicki proposed a better offer to acquire the bankrupt DNA testing company.

20hon MSN

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

18hon MSN

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

1hon MSN

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results